| 标题 |
Fixed-dose combination bictegravir–emtricitabine–tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet HIV 作者:Anushka Naidoo; Kogieleum Naidoo; Marothi P Letsoalo; Roeland E Wasmann; Gillian Dorse; et al 出版日期:2025-12-02 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)